Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cystoid macular edema in uveitis.

Narciss Okhravi1, Susan Lightman

  • 1Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK. nokhravi@hgmp.mrc.ac.uk

Ocular Immunology and Inflammation
|July 11, 2003
PubMed
Summary

Cystoid macular edema (CME) causes vision loss in uveitis patients. While some cases respond to inflammation treatment, others become resistant, leading to severe visual impairment despite aggressive therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgically induced scleritis after pars plana vitrectomy or scleral buckling surgery: a 12-year audit.

Eye (London, England)·2025
Same author

Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes.

Eye (London, England)·2023
Same author

Acute posterior multifocal placoid pigment epitheliopathy: clinical presentation and risk of stroke and transient ischaemic attack.

The British journal of ophthalmology·2023
Same author

The role of statins in diabetic retinopathy.

Trends in cardiovascular medicine·2022
Same author

Successful treatment of cytomegalovirus retinitis with oral/intravitreal antivirals in HIV-negative patients with lymphoma.

Eye (London, England)·2022
Same author

Online live clinical skills teaching with dual cameras.

Medical education·2022

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Cystoid macular edema (CME) is a significant cause of vision loss and legal blindness in uveitis patients.
  • CME can occur with any form of uveitis, whether acute or chronic, affecting the anterior or posterior segments of the eye.

Purpose of the Study:

  • To review the impact of cystoid macular edema in uveitis patients.
  • To discuss current and potential treatment strategies for CME in uveitis.

Main Methods:

  • Literature review of studies on cystoid macular edema and uveitis.
  • Analysis of treatment outcomes for CME in the context of intraocular inflammation.

Main Results:

  • Mild, short-term CME may resolve with treatments targeting intraocular inflammation.
  • More severe or persistent CME often requires aggressive therapies, including local/systemic steroids and immunosuppressants.

Conclusions:

  • Cystoid macular edema is a challenging complication of uveitis with a significant risk of severe visual loss.
  • Refractory CME poses a therapeutic challenge, often resisting current treatment modalities and leading to irreversible vision impairment.

Related Experiment Videos